Hereditary and acquired thrombophilia in patients with upper extremity deep-vein thrombosis: Results from the MAISTHRO registry

Thrombosis and Haemostasis

Volumn 100, Issue 3, 2008, Pages 440-446

  Linnemann, Birgit ^a   Meister, Florian ^a   Schwonberg, Jan ^a   Schindewolf, Marc ^a   Zgouras, Dimitrios ^a   Lindhoff Last, Edelgard ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Factor VIII; Malignancy; Thrombophilia; Upper extremity DVT; Venous catheters

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 8; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTEIN S; PROTHROMBIN;

ADOLESCENT; ADULT; AGED; ARM; ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; GENETIC DISORDER; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; THROMBOPHILIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COHORT STUDIES; FACTOR VIII; FEMALE; HUMANS; MALE; MIDDLE AGED; REGISTRIES; THROMBOPHILIA; UPPER EXTREMITY; VENOUS THROMBOSIS;

EID: 51349124271     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH08-03-0196     Document Type: Article

References (33)

1. Spencer FA, Emery C, Lessard D, Goldberg RJ, for the Worcester Venous Thromboembolism Study. Upper extremity deep vein thrombosis: a community-based perspective. Am J Med 2007; 120: 678-684.
2. Zell L, Kindermann W, Marschall F, et al. Paget-Schroetter syndrome in sports activities. Case study and literature review. Angiology 2001; 52: 337-342.
3. van Stralen, KJ, Blom JW, Doggen CJM, et al. J Thromb Haemost 2005; 3: 2110-2111.
4. Parziale JR, Akelman E, Weiss AC, et al. Thoracic outlet syndrome. Am J Orthoped 2000; 29: 353-360.
5. Joffe HV, Goldhaber SZ. Upper-extremity deep vein thrombosis. Circulation 2002; 106: 1874-1880.
6. Blom JW, Doggen CJM, Soanto S, et al. Old and new risk factors for upper extremity deep venous thrombosis. J Thromb Haemost 2005; 3: 2471-2478.
7. Chan WS, Ginsberg JS. A review of upper extremity deep vein thrombosis in pregnancy: unmasking the 'ART' behind the clot. J Thromb Haemost 2006; 4: 1673-1677.
8. Bauersachs RM, Manolopoulos K, Hoppe I, et al. More on: the 'ART' behind the clot: solving the mystery. J Thromb Haemost 2007; 5: 438-439.
9. Hendler MF, Meschengieser SS, Blanco AN, et al. Primary upper-extremity deep vein thrombosis: high prevalence of thrombophilic defects. Am J Hematol 2004; 76: 330-337.
10. Martinelli I, Cattaneo M, Panzeri D, et al. Risk factors for deep venous thrombosis of the upper extremities. Ann Intern Med 1997; 126: 707-711.
11. Prandoni P, Polistena P, Bernardi E, et al. Upper-extremity deep vein thrombosis. Risk factors, diagnosis, and complications. Arch Intern Med 1997; 157: 57-62.
12. Lindhoff-Last E, Bauersachs R, Jesgarz J et al. The german thrombophilia registry. Ann Hematol 2001; 80(Suppl1): A43.
13. van Rooden CJ, Tesselaar MET, Osanto S, et al. Deep vein thrombosis associated with central venous catheters - a review. J Thromb Haemost 2005; 3: 2409-2419.
14. Baarslag HJ, Koopman MMW, Reekers JA, et al. Diagnosis and management of deep vein thrombosis of the upper extremity: a review. Eur Radiol 2004; 14: 1263-1274.
15. Linnemann B, Schindewolf M, Zgouras D, et al. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis? Thromb Res 2008; 121: 743-750.
16. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 1995; 74: 1185-1190.
17. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
18. Bombeli T, Basic A, Fehr J. Prevalence of hereditary thrombophilia in patients with thrombosis in dif ferent venous systems. Am J Hematol 2002; 70: 126-132.
19. Heron E, Lozinguez O, Alhenc-Gelas M, et al. Hypercoagulable states in primary upper-extremity deep vein thrombosis. Arch Intern Med 2000; 160: 382-386.
20. Martinelli I, Battaglioli T, Bucciarelli P, et al. Risk factors and recurrence of primary deep vein thrombosis of the upper extremities. Circulation 2004; 110: 566-570.
21. Ruggeri M, Castaman G, Tosetto A, et al. Low prevalence of thrombophilic coagulation defects in patients with deep vein thrombosis of the upper limbs. Blood Coagul Fibrinolysis 1997; 8: 191-194.
22. Leebeek FWG, Stadhouders NAM, van Stein D, et al. Hypercoagulability states in upper-extremity deep venous thrombosis. Am J Hematol 2001; 67: 15-19.
23. Kamphuisen PW, Eikenboom JCJ, Bertina RM. Elevated factor VIII levels and the risk of thrombosis. Arterioscler Thromb Vasc Biol 2001; 21: 731-738.
24. Bank I, van de Poel HW, Coppens M, et al. Absolutes annual incidences of first events of venous thromboembolism and arterial vascular events in individuals with elevated FVIII:c. Thromb Haemost 2007; 98: 1040-1044.
25. Munoz FJ, Mismitti P, Poggio R, et al., for the RIETE investigators. Clinical outcome of patients with upper-extremity deep vein thrombosis. Results from the RIETE registry. Chest 2008; 133: 143-148.
26. Constans J, Salmi LR, Sevestre-Pietri MA, et al. A clinical prediction score for upper extremity deep venous thrombosis. Thromb Haemost 2008; 99: 202-207.
27. Seddighzadeh A, Shetty R, Goldhaber SZ. Venous thromboembolism in patients with active cancer. Thromb Haemost 2007; 98: 656-661.
28. Anderson FA, Spencer FA. Risk factors for venous thromboembolism. Circulation 2003; 107: I-9-I-16.
29. Schambeck CM in Bruhn HD, Schambeck CM, Hach-Wunderle V. Hämostaseologie für die Praxis. Schattauer, Stuttgart, Germany, 2007.
30. Joffe HV, Kucher N, Tapson VF, et al. Upper-extremity deep vein thrombosis: a prospective registry of 592 patients. Circulation 2004; 110: 1605-1611.
31. Hughes ES. Venous obstruction in upper extremity (Paget-Schroetter's syndrome). Review of 320 cases. Int Abstr Surg 1949; 88: 89-127.
32. Ellis MH, Manor Y, Witz M. Risk factors and management of patients with upper limb deep vein thrombosis. Chest 2000; 117: 43-49.
33. Vayá A, Mira Y, Mateo J, et al. Prothrombin G20210A and oral contraceptive use increase upper-extremity deep vein thrombotic risk. Thromb Haemost 2003; 89: 452-458.